Journal for ImmunoTherapy of Cancer (Mar 2019)
Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
- Asim Amin,
- Elizabeth R. Plimack,
- Marc S. Ernstoff,
- Lionel D. Lewis,
- Todd M. Bauer,
- David F. McDermott,
- Michael Carducci,
- Christian Kollmannsberger,
- Brian I. Rini,
- Daniel Y. C. Heng,
- Jennifer Knox,
- Martin H. Voss,
- Jennifer Spratlin,
- Elmer Berghorn,
- Lingfeng Yang,
- Hans J. Hammers
Affiliations
- Asim Amin
- Immunotherapy program, Levine Cancer Institute, Carolinas HealthCare System
- Elizabeth R. Plimack
- Division of Genitourinary Medical Oncology, Department of Hematology/Oncology, Fox Chase Cancer Center
- Marc S. Ernstoff
- Division of Oncology, Department of Medicine, Roswell Park Cancer Institute
- Lionel D. Lewis
- Department of Medicine at The Geisel School of Medicine and The Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
- Todd M. Bauer
- Sarah Cannon Research Institute/Tennessee Oncology, PLLC
- David F. McDermott
- Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center
- Michael Carducci
- Department of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
- Christian Kollmannsberger
- Division of Medical Oncology, British Columbia Cancer Agency
- Brian I. Rini
- Lerner College of Medicine, Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute
- Daniel Y. C. Heng
- Department of Oncology, Tom Baker Cancer Center, University of Calgary
- Jennifer Knox
- Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
- Martin H. Voss
- Department of Medicine, Memorial Sloan Kettering Cancer Center
- Jennifer Spratlin
- Department of Oncology, Cross Cancer Institute, University of Alberta
- Elmer Berghorn
- Oncology - Global Clinical Research, Bristol-Myers Squibb
- Lingfeng Yang
- Oncology - Global Clinical Research, Bristol-Myers Squibb
- Hans J. Hammers
- Department of Internal Medicine, UT Southwestern – Kidney Cancer Program
- DOI
- https://doi.org/10.1186/s40425-019-0559-3
- Journal volume & issue
-
Vol. 7,
no. 1
pp. 1 – 1
Abstract
.
